Research / LYB / Fundamental state Inspectable configuration
State dimensions Filing 0001489393-26-000061 General Corporate
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.94% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
8.19% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
19.84% · CORE · VALID
Inventory pressure 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
44.45% · OPTIONAL · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.81% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.37% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.21% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 3.74%
Current 2.94%
Delta -0.80% Cash Generation Increased
Previous -3.74%
Current 8.19%
Delta 11.93% Growth Increased
Previous -6.25%
Current 19.84%
Delta 26.09% Inventory Pressure Decreased
Previous 50.51%
Current 44.45%
Delta -6.06% Profitability Increased
Previous 3.32%
Current 16.81%
Delta 13.49% R And D Intensity Decreased
Previous 0.50%
Current 0.37%
Delta -0.13% Sbc Intensity Decreased
Previous 0.65%
Current 0.21%
Delta -0.45% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Sep 30, 2024
Similarity 73%
Compared 7 dimensions
Coverage 100% Growth 20.0 · Profitability 50.0 · Sbc Intensity 5.0 · Capex Intensity 15.0 · Cash Generation 20.0 · R And D Intensity 35.0 · Inventory Pressure 15.0 Mar 31, 2021
Similarity 72%
Compared 7 dimensions
Coverage 100% Growth 15.9 · Profitability 50.0 · Sbc Intensity 34.6 · Capex Intensity 6.7 · Cash Generation 35.0 · R And D Intensity 1.7 · Inventory Pressure 16.7 Jun 30, 2022
Similarity 66%
Compared 7 dimensions
Coverage 100% Growth 0.0 · Profitability 30.0 · Sbc Intensity 27.8 · Capex Intensity 5.0 · Cash Generation 15.0 · R And D Intensity 75.0 · Inventory Pressure 25.0 Sep 30, 2023
Similarity 64%
Compared 7 dimensions
Coverage 100% Growth 30.0 · Profitability 60.0 · Sbc Intensity 30.0 · Capex Intensity 25.0 · Cash Generation 40.0 · R And D Intensity 40.0 · Inventory Pressure 0.0 Sep 30, 2021
Similarity 64%
Compared 7 dimensions
Coverage 100% Growth 17.3 · Profitability 1.8 · Sbc Intensity 30.0 · Capex Intensity 17.6 · Cash Generation 41.5 · R And D Intensity 75.0 · Inventory Pressure 20.6 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.